Sreeram Ramagopalan, PhD

ADHD lowers the quality of life in adults with epilepsy; epilepsy is associated with social deprivation and increased risk of venous thromboembolism: details of these recent findings in this slide show.

Three brand new studies shed light on use of natalizumab in relapsing-remitting multiple sclerosis.

Studies suggest that acupuncture can improve MS-related symptoms, but poor design makes it difficult to draw robust conclusions.

This, the least common MS disease course, carries the worst prognosis. Treatments are urgently needed to prevent or delay the rapid disease progression.

Childhood obesity is another potentially modifiable factor to reduce the risk of multiple sclerosis.

Hospitalization rates have declined dramatically in the MS population but remain higher than in the general population. That may be because of the availability of MS disease-modifying treatments.

Information on causes of death for patients with MS is limited, but these researchers came up with some of the underlying causes.

A significant percentage of patients with MS in the sample screened positive for 1 or more sleep disorders. Most were undiagnosed.

This study identified that suicidal thoughts are common and several potentially modifiable factors may be useful for prevention.

This study found a positive relationship between physical disability and anxiety and depression, pointing to a need for routine evaluation.

Vitamin D levels during pregnancy do not appear to influence MS risk to any substantial extent.

Given the data from Denmark, being infected with HIV does seem to be “protective” against MS development.

Several lines of evidence indicate that gender affects the susceptibility and course of MS with a higher disease prevalence and overall better prognosis in women.

A new study puts a final nail in the coffin for the hypothesis that chronic cerebrospinal venous insufficiency is neither specific or causative for multiple sclerosis.

In this study, high-dose simvastatin reduced the annualized rate of whole-brain atrophy in secondary progressive MS.

For people with MS, smoking is associated with more severe disease and faster disability progression. Smoking cessation before or after disease onset is associated with slower progression of disability.